Picture Name

Medical Health Innovation Project Settled in Jinling -- "New Blood Pathogen Inactivation Project" Successfully Signed

23 Oct,2019

On October 22, Nanjing Shuangwei Biomedical Technology Co., Ltd. and the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences held a project cooperation signing ceremony on "Industrialization of Technical Achievements of Blood Pathogen Inactivation System" in Shuangwei Biological Industrial Park. Sunway Biology has long focused on the development and production of blood component treatment medical devices for transfusion in the field of safe blood transfusion. The Institute of Blood Transfusion of the Chinese Academy of Medical Sciences is a national blood transfusion medical research institution. Under the guidance of the Chinese Medical Health Innovation Project, a new type of blood pathogen inactivation project has been developed, which can further reduce the risk of pathogen transmission. In order to make this project better serve the society, the two sides held consultations for half a year and finally signed the contract smoothly. The achievement of this cooperation will further improve the level of blood safety, and at the same time will have long-term significance for enhancing the international competitiveness of medical devices in the field of safe blood transfusion in my country. Once the results of this innovative project are completed, it will fill the domestic gap.

The signing ceremony invited Lu Dingming, Deputy Secretary of the Party Working Committee of the Life and Health Industry Development Management Office of Jiangbei New District, Xu Shoumiao, Deputy Director of the Life and Health Industry Development Management Office of Jiangbei New District, Bai Hongshu, Director of the Consumer Goods Industry Division of Nanjing Municipal Bureau of Industry and Information Technology, and Jiangbei New District Science and Technology Han Chen, Chief of the Industry-University-Research Cooperation Office of the Innovation Bureau, He Guangming, at the same time, the guests and leaders who participated in the signing ceremony included Chen Yongjun, Secretary of the Party Committee of the Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Liu Zhong, Deputy Director, and related representatives, Liu Yuqing, Chairman of Nanjing Tongtian Technology Industry Co., Ltd., Wang Weifeng, Secretary of the Party Branch, and Shuangwei Biology Chairman Xiao Guofeng and other related leaders.

The signing ceremony was presided over by Zhou Jun, general manager of Shuangwei Biology. After the leaders of Nanjing Jiangbei New District, the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences and Shuangwei Biology took the stage to introduce the background to each other and congratulate the signing ceremony, Chen Yongjun, Liu Zhong, Xiao Guofeng and Li Zheng signed the contract on behalf of the Institute of Blood Transfusion and Shuangwei Biology respectively, and took photos with all the guests.

After the signing ceremony, the guests visited the project site of the R & D base of Sunway Biological Company and learned in detail about technology research and development, project construction, and spatial planning. During this period, the leaders of the Life and Health Industry Development Management Office of Jiangbei New District spoke highly of the ethylene oxide sterilization workshop in the industrial park, and the leaders of the Blood Transfusion Research Institute had high hopes for the overall laboratory construction and technical quality projects.

In the future, Sunway Biology will work more closely with the Institute of Blood Transfusion of the Chinese Academy of Medical Sciences, centering on the important guiding ideology of the "Healthy China 2030" Planning Outline, continue to focus on the R & D and production in the field of safe blood transfusion, and give full play to the advantages of cooperation between enterprises and institutes. Promote the construction of a healthy China, overcome difficulties, forge ahead pragmatically, and transform the huge potential of the development of both enterprises and institutes into tangible results, work together to build China's safe blood transfusion industry base and improve people's health!